Back to search
Neuronal Ceroid Lipofuscinosis CLN5
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neuronal Ceroid Lipofuscinosis CLN5 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neuronal Ceroid Lipofuscinosis CLN5 trials you may qualify forThis study aims to assess the natural history of Batten disease (Neuronal Ceroid Lipofuscinosis) by obtaining information about the motor, behavioral, and funct…
This is an observational study that aims at assessing the natural history of NCL diseases as part of the international DEM-CHILD Database. 1. Patient data are…
This is a prospective, non-randomized, open-label, dose escalation study of a single administration of gene therapy in children who are 3 to 9 years old with Ne…
CLN5 is a form of Batten Disease, a neurodegenerative disorder in children causing psychomotor regression, seizures, blindness, loss of ambulation and premature…